# Human Longevity

Human Longevity is an other based in San Diego, United States.

## Overview

- **Organization type:** other
- **Headquarters:** San Diego, United States
- **Region:** North America
- **Address:** San Diego, CA, United States
- **Founded:** 2013
- **Assets under management:** Undisclosed
- **Website:** humanlongevity.com
- **LinkedIn:** https://www.linkedin.com/company/human-longevity-inc-

## Regulatory record

- **Reports private funds:** No

## About

The most comprehensive executive health assessment — full-body MRI, whole genome sequencing, 120+ biomarkers & AI analysis in one visit. Starting at $8,000.

## Sectors

- Healthcare Services
- AI/ML

## Offices

- San Francisco, CA, United States

## People

- Dr. J. Craig Venter — Co-Founder
- Tina Ziainia, MD, FACOG — President & Medical Director — San Diego
- Keon Pearson, MD, MBA — Medical Director — San Francisco & Director, Executive Health
- David Karow, MD, PhD — Chief Clinical Advisor

## Questions

### Who runs the clinical team at Human Longevity?

The clinical team is led by Dr. Tina Ziainia, President and Medical Director of the San Diego clinic, and Dr. Keon Pearson, Medical Director of the San Francisco clinic and Director of Executive Health. Dr. David Karow serves as Chief Clinical Advisor. All clinicians are board-certified and trained at institutions including Stanford, Harvard, UCSF, and the Cleveland Clinic (per firm website).

### What does the Human Longevity assessment include?

The standard program includes whole genome sequencing, whole body MRI with NeuroQuant, brain MRI, echocardiogram, EKG, CT calcium score, DEXA scan, and 120+ blood biomarkers. The premium tier adds a continuous glucose monitor, Zio Patch cardiac monitoring, GRAIL multi-cancer blood test, cardiac MRI, low-dose CT of the lung, and quarterly physician follow-ups (per firm website, 2026).

### How is Dr. J. Craig Venter involved with the firm today?

Dr. J. Craig Venter is listed as co-founder on the firm's website. His role in day-to-day operations is not disclosed, but his scientific legacy — sequencing the first human genome in 2000 — directly underlies the firm's approach. The firm continues to reference his work in its marketing and research publications (per firm website).

### What is the scientific evidence behind Human Longevity's protocols?

The firm reports over 20 peer-reviewed publications in journals including Nature Genetics, PNAS, and Genome Medicine. A 2020 PNAS paper by Venter et al. demonstrated its approach to phenotypic aging analysis. The firm is ranked among the top 50 biomedical companies globally by Nature Index (per firm website).

### How does Human Longevity use artificial intelligence?

The firm offers a Longevity AI app that translates complex diagnostic data into personalized recommendations. Geoffrey Hinton, Nobel laureate and pioneer of deep learning, sits on the Scientific Advisory Board. The firm uses AI to analyze whole genome sequences, MRI images, and biomarker data for early disease detection (per firm website).

## Related profiles

- [Emerging Technologies Ltd](https://altss.com/profile/emerging-technologies-ltd)
- [Nascita Ventures](https://altss.com/profile/nascita-ventures-llc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/human-longevity

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology